Akerna Story

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;'>AC</div>
KERN -- USA Stock  

USD 5.68  0.25  4.22%

Akerna Corp Net Cash Flow or Change in Cash and Cash Equivalents is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow or Change in Cash and Cash Equivalents is estimated at 2.7 Million. Issuance Purchase of Equity Shares is expected to rise to about 5.5 M this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (13.9 M). As some conservative investors are getting more into healthcare space, Akerna Corp Cl could be a your radar. I will take a closer look at this stock and the latest sentiment generated by institutional investors. Here I will also outline some basic indicators that Akerna Corp investors should consider in February.
Published over a week ago
View all stories for Akerna Corp | View All Stories
Akerna Corp (NASDAQ:KERN) continues to rise
The company is overvalued at 4.33 per share with modest projections ahead. On a scale of 0 to 100, Akerna Corp holds a performance score of 6. The firm shows a Beta (market volatility) of 3.0581, which signifies a somewhat significant risk relative to the market. Let's try to break down what Akerna's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Akerna Corp will likely underperform. Although it is vital to follow Akerna Corp Cl historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-seven technical indicators for Akerna Corp Cl, which you can use to evaluate the performance of the firm. Please makes use of Akerna Corp Cl value at risk, and the relationship between the jensen alpha and skewness to make a quick decision on whether Akerna Corp price patterns will revert.

How important is Akerna Corp's Liquidity

Akerna Corp financial leverage refers to using borrowed capital as a funding source to finance Akerna Corp Cl ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Akerna Corp financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Akerna Corp's total debt and its cash.

How Akerna utilizes its cash?

To perform a cash flow analysis of Akerna Corp, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Akerna Corp is receiving and how much cash it distributes out in a given period. The Akerna Corp cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Akerna Corp Net Cash Flow from Operations is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (13.93 Million)

What did Akerna Corp file with SEC?

The SEC filings are financial statements or other formal documents of Akerna Corp Cl that are regularly submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make SEC filings and fintech professionals rely on these filings for information about companies they are evaluating for investment purposes. Please note, most SEC filings are available online through the SEC's EDGAR database. Please check here for more information.
Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to Akerna shareholders may or may not be submitted as SEC does not always require it.
Unregistered Sales of Equity Securities
View
Entry into a Material Definitive Agreement
View
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
Other Events
View
Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to Akerna shareholders may or may not be submitted as SEC does not always require it.

Acquisition by Iwanowski Mark of 1992 shares of Akerna Corp subject to Rule 16b-3

Legal trades by Akerna Corp insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Akerna insider trading alert for grant of restricted stock units by Iwanowski Mark, the corporate stakeholder, on 6th of October 2020. This event was filed by Akerna Corp with SEC on 2020-10-06. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking it down a bit more

Akerna Corp Cl retains a total of 19.69 Million outstanding shares. Akerna Corp Cl retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
 2018 2019 2020 2021 (projected)
Revenues USD10.82 M12.57 M14.46 M14.15 M
Revenues10.82 M12.57 M14.46 M14.15 M

Ownership Breakdown

Retail Investors
51.59%
Insiders
39.05%
Institutions
9.36%
Retail Investors51.59
Insiders39.05
Institutions9.36

Our perspective of the latest Akerna Corp rise

The market risk adjusted performance is down to 0.24 as of today. Akerna Corp Cl is displaying above-average volatility over the selected time horizon. Investors should scrutinize Akerna Corp Cl independently to ensure intended market timing strategies are aligned with expectations about Akerna Corp volatility.

The Current Takeaway on Akerna Corp Investment

Whereas some other companies under the health information services industry are still a bit expensive, Akerna Corp may offer a potential longer-term growth to institutional investors. All things considered, as of the 8th of January 2021, we believe that Akerna Corp is currently overvalued with below average chance of distress in the next two years. Our primary 30 days buy-or-sell advice on the company is Strong Sell.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Akerna Corp Cl. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com